Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Change in Cash (2021 - 2025)

Core Scientific's Change in Cash history spans 5 years, with the latest figure at -$142.1 million for Q4 2025.

  • For Q4 2025, Change in Cash fell 124.36% year-over-year to -$142.1 million; the TTM value through Dec 2025 reached -$525.6 million, down 168.5%, while the annual FY2025 figure was -$525.6 million, 168.5% down from the prior year.
  • Change in Cash for Q4 2025 was -$142.1 million at Core Scientific, down from -$127.9 million in the prior quarter.
  • Across five years, Change in Cash topped out at $583.2 million in Q4 2024 and bottomed at -$142.1 million in Q4 2025.
  • The 5-year median for Change in Cash is $6.6 million (2023), against an average of $15.1 million.
  • The largest annual shift saw Change in Cash skyrocketed 10014.08% in 2024 before it plummeted 583.59% in 2025.
  • A 5-year view of Change in Cash shows it stood at -$28.3 million in 2021, then soared by 151.52% to $14.6 million in 2022, then tumbled by 60.5% to $5.8 million in 2023, then surged by 10014.08% to $583.2 million in 2024, then plummeted by 124.36% to -$142.1 million in 2025.
  • Per Business Quant, the three most recent readings for CORZ's Change in Cash are -$142.1 million (Q4 2025), -$127.9 million (Q3 2025), and -$117.4 million (Q2 2025).